Publikation
First-in-human study of CH5132799, an oral class I PI3K inhibitor, studying toxicity, pharmacokinetics, and pharmacodynamics, in patients with metastatic cancer
Wissenschaftlicher Artikel/Review - 17.09.2014
Blagden Sarah, Spicer James, Twelves Chris, Jones Keith, Prince Jenny, Inatani Michiyasu, Shiokawa Rie, Noguchi Kohei, Pope Lorna, Riisnaes Ruth, Swales Karen, Decordova Shaun, Anthoney Alan, Pinato David J, Zivi Andrea, Stavraka Chara, Josephs Debra, Omlin Aurelius, Banerji Udai
Blagden, Sarah
1
0
Omlin, Aurelius
114
14
Josephs, Debra
1
0
Stavraka, Chara
1
0
Zivi, Andrea
6
0
Pinato, David J
1
0
Anthoney, Alan
1
0
Decordova, Shaun
1
0
Swales, Karen
1
0
Riisnaes, Ruth
5
0
Pope, Lorna
1
0
Noguchi, Kohei
1
0
Shiokawa, Rie
1
0
Inatani, Michiyasu
1
0
Prince, Jenny
1
0
Jones, Keith
1
0
Twelves, Chris
3
0
Spicer, James
1
0
Banerji, Udai
1
0